NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 324 filers reported holding NATERA INC in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,321,113 | -2.4% | 142,850 | +7.3% | 0.08% | +31.6% |
| Q2 2023 | $6,476,403 | -26.8% | 133,095 | -16.4% | 0.06% | -33.7% |
| Q1 2023 | $8,843,836 | +28.8% | 159,291 | -6.8% | 0.09% | +19.4% |
| Q4 2022 | $6,867,021 | -99.9% | 170,949 | +1.8% | 0.07% | -10.0% |
| Q3 2022 | $7,358,298,000 | +98536.7% | 167,921 | -20.2% | 0.08% | +8.1% |
| Q2 2022 | $7,460,000 | -5.4% | 210,510 | +8.6% | 0.07% | +21.3% |
| Q1 2022 | $7,886,000 | -65.4% | 193,861 | -20.6% | 0.06% | -27.4% |
| Q4 2021 | $22,802,000 | +956.6% | 244,162 | +1161.1% | 0.08% | +281.8% |
| Q3 2021 | $2,158,000 | +11.0% | 19,361 | +13.0% | 0.02% | 0.0% |
| Q2 2021 | $1,945,000 | +17.4% | 17,133 | +5.0% | 0.02% | +4.8% |
| Q1 2021 | $1,657,000 | – | 16,323 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |